Dillman Jonathan R, Rubin Jonathan M, Johnson Laura A, Moons David S, Higgins Peter D R
Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan, USA.
J Ultrasound Med. 2017 Mar;36(3):523-530. doi: 10.7863/ultra.16.04064. Epub 2017 Jan 10.
To determine whether contrast-enhanced sonographic quantitative perfusion parameters can detect bowel wall fibrosis in the setting of mixed inflammatory and fibrotic lesions in a Crohn disease animal model.
This study was approved by the institutional Committee on the Use and Care of Animals. Multiple (range, 1-5) 2,4,6-trinitrobenzenesulfonic acid-ethanol enemas were used to create intestinal inflammatory lesions with variable fibrosis in female Lewis rats. Low-mechanical index contrast-enhanced sonography was performed 3 days after the final enema using a 0.2-mL bolus of sulfur hexafluoride microbubbles injected through a tail vein. Contrast-enhanced sonographic data were analyzed with software that converts video data into echo-power (linearized) data. Colorectal lesions were scored for histopathologic inflammation and fibrosis; bowel wall collagen was quantified by Western blotting. The Spearman correlation was used to assess associations between contrast-enhanced sonographic quantitative parameters and bowel wall collagen; the Kruskal-Wallis test was used to compare continuous results between histopathologic groups.
Thirty-one animals were included in our analysis. Animals were placed into 3 histopathologic cohorts: (1) severe bowel wall inflammation/minimal or no fibrosis (n = 11); (2) severe bowel wall inflammation/moderate fibrosis (n = 9); and (3) severe bowel wall inflammation/severe fibrosis (n = 11). Western blotting showed a significant difference in bowel wall collagen between histopathologic cohorts (P = .0001). There was no correlation between any contrast-enhanced sonographic quantitative parameter and bowel wall collagen (P > .05). There was no difference between histopathologic cohorts for any contrast-enhanced sonographic quantitative parameter (P > .05).
Contrast-enhanced sonographic quantitative perfusion parameters failed to effectively detect bowel wall fibrosis in the setting of superimposed inflammation in a Crohn disease animal model.
确定在克罗恩病动物模型中,超声造影定量灌注参数能否在混合性炎症和纤维化病变情况下检测出肠壁纤维化。
本研究经机构动物使用与护理委员会批准。对雌性Lewis大鼠多次(范围为1 - 5次)给予2,4,6 - 三硝基苯磺酸 - 乙醇灌肠,以制造具有不同纤维化程度的肠道炎性病变。在最后一次灌肠3天后,经尾静脉注射0.2 mL六氟化硫微泡团注,进行低机械指数超声造影检查。使用将视频数据转换为回波功率(线性化)数据的软件分析超声造影数据。对结直肠病变进行组织病理学炎症和纤维化评分;通过蛋白质免疫印迹法定量肠壁胶原蛋白。采用Spearman相关性分析评估超声造影定量参数与肠壁胶原蛋白之间的关联;使用Kruskal - Wallis检验比较组织病理学组之间的连续结果。
31只动物纳入我们的分析。动物被分为3个组织病理学队列:(1)严重肠壁炎症/极少或无纤维化(n = 11);(2)严重肠壁炎症/中度纤维化(n = 9);(3)严重肠壁炎症/严重纤维化(n = 11)。蛋白质免疫印迹法显示组织病理学队列之间肠壁胶原蛋白存在显著差异(P = 0.0001)。任何超声造影定量参数与肠壁胶原蛋白之间均无相关性(P > 0.05)。各组织病理学队列之间任何超声造影定量参数均无差异(P > 0.05)。
在克罗恩病动物模型中,超声造影定量灌注参数未能在叠加炎症情况下有效检测出肠壁纤维化。